HCA Healthcare saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 63 to 72.
This unique rating measures market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Over 100 years of market history reveals that the best-performing stocks typically have an 80 or better RS Rating as they begin their biggest climbs. See if HCA Healthcare can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
HCA Healthcare is working on a consolidation with a 417.14 entry. See if it can clear the breakout price in heavy volume.
HCA Healthcare posted 5% earnings growth last quarter. Revenue gains came in at 6%. The company is expected to report its latest performance numbers on or around Apr. 18.
The company earns the No. 6 rank among its peers in the Medical-Hospitals industry group. Tenet Healthcare, Universal Health Cl B and Nutex Health are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
